A02244 ((5S,10S,11S,14S)-11-苄基-5-(叔丁基)-10-羟基-15,15-二甲基-3,6,13-三氧代-8-(4-(吡啶-2-基)苄基)-2-氧杂-4,7,8,12-四氮杂十六烷-14-基)氨基甲酸甲酯硫酸盐

Methyl ((5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl)carbamate sulfate

别名：阿扎那韦;阿扎那韦硫酸盐;阿扎那韦硫酸盐 USP标准品;二氟甲基 (2-吡啶基)砜;硫酸阿扎那韦;西洛司特阿扎那韦;阿扎那韦硫酸盐;阿扎那韦硫酸盐 USP标准品;二氟甲基 (2-吡啶基)砜;硫酸阿扎那韦;西洛司特展开

CAS No. : 229975-97-7

分子式： C₃₈H₅₄N₆O₁₁S

分子量： 802.9340

大包装询价? 收藏产品

自营

货号	规格	目录价
A02244-250mg	250mg	¥78.00
A02244-1g	1g	¥138.00
A02244-5g	5g	¥498.00
A02244-25g	25g	¥1588.00

中文名称	((5S,10S,11S,14S)-11-苄基-5-(叔丁基)-10-羟基-15,15-二甲基-3,6,13-三氧代-8-(4-(吡啶-2-基)苄基)-2-氧杂-4,7,8,12-四氮杂十六烷-14-基)氨基甲酸甲酯硫酸盐
中文别名	阿扎那韦;阿扎那韦硫酸盐;阿扎那韦硫酸盐 USP标准品;二氟甲基 (2-吡啶基)砜;硫酸阿扎那韦;西洛司特
英文名称	Methyl ((5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl)carbamate sulfate
英文别名	Atazanavir Sulfate;Atazanavir Sulphate;Methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamate sulfate;Atazanavir sulfate (BMS-232632-05, CGP 73547 sulfate, Reyataz®);Atazanavir Bisulfate Salt;Atazanavir Bisulfate Salt See A790051;Atazanavir Bisulfate SaltSee A790051;BMS 232632 sulfate;BMS-232632 sulfate;Dimethyl (3S,8S,9S,12S)-9-benzyl-3,12,di-tert-butyl-8-hydroxy-4,11-dioxo-6-(p-2-pyridylbenzyl)-2,5,6,10,13-pentaazatetradecanedioate sulfate (1:1);Methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamat;Reyataz;Atazanavir (sulfate);Atazanavir sulfate [USAN];4MT4VIE29P;Reyataz (TN);Atazanavir sulfate;2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, 1,14-dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1);ATAZANAVIR SULFATE [JAN];3-AMINO-3-(3-BENZYLOXY-PHENYL)-PROPIONICACID;Atazanavir so4;CS-1890;CHEBI:31243;ATAZANAVIRI SULFAS [WHO-IP LATIN];MLS006010199;2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt);methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate;sulfuric acid;ATAZANAVIR SULFATE [MI];DTXCID801475397;s1457;D01276;HY-17367A;Atazanavir sulfate (JAN/USAN);ATAZANAVIR SO4 [VANDF];DTXSID401017206;NSC 742546;ATAZANAVIR SULFATE (USP-RS);SW220258-1;ATAZANAVIR SULFATE [EP MONOGRAPH];2,5,6,10,13-Pentaazatetradecanedioic acid, 3-12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((-4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt);2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt);229975-97-7;ATAZANAVIR SULFATE [WHO-DD];ATAZANAVIR SULFATE COMPONENT OF EVOTAZ;UNII-4MT4VIE29P;SMR002544693;J-014934;methyl ((5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl)carbamate sulfate;AKOS016000176;Q27114238;ATAZANAVIR SULFATE [MART.];MLS003915641;BMS-232632-05, Reyataz;AS-14954;BMS-232632-05;Atazanavir sulphate;229975-97-7 (sulfate);ATAZANAVIR SULFATE (MART.);ATAZANAVIR SULFATE [WHO-IP];EX-A4010;SCHEMBL341700;Dimethyl (3S,8S,9S,12S)-9-benzyl-3,12,di-tert-butyl-8-hydroxy-4,11-dioxo-6-(p-2-pyri...
CAS No.	229975-97-7
分子式	C₃₈H₅₄N₆O₁₁S
分子量	802.93
密度	1.164
沸点	995.5 °C at 760 mmHg
纯度	98.00%